Newsletter February 2026
EPO at the 37th German Cancer Congress
Dear colleagues,
we are pleased to share that Michelle Zimmer will be presenting a scientific poster at the 37th German Cancer Congress.
The poster introduces a microfluidic Organ-on-Chip model of the blood–brain barrier (BBB), enabling physiologically relevant in vitro assessment of drug penetration and therapeutic potential. This innovative platform supports the development of novel treatment strategies for glioblastoma by improving the predictive value of preclinical BBB models.
"Meet the Expert" at the German Cancer Congress
We are also delighted to invite you to meet Jens Hoffmann at the German Cancer Congress. As a leading expert in experimental pharmacology and oncology, Jens will be attending the meeting and is looking forward to connecting with colleagues from academia and industry.
? Schedule a meeting with Jens Hoffmann here:
We look forward to exchanging ideas and discussing innovative preclinical approaches with you in Berlin.
Best wishes,
Jens Hoffmann, Wolfgang Walther & Antje Wengner